Independent Research & Reviews
AffordableGLP-1
Provider Comparison

Wegovy vs Zepbound: Which GLP-1 Medication is Better in 2026?

Updated May 2026

W

Wegovy

90Excellent
vs
Z

Zepbound

92Excellent

We may earn a commission from links on this page. Learn more

Our Verdict

Winner: Zepbound

Both Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved, highly effective weight loss medications. Zepbound shows slightly higher average weight loss in clinical trials (up to 22% vs 15%) due to its dual GLP-1/GIP action. Wegovy has more long-term safety data and wider availability. For maximum weight loss potential, Zepbound has the edge. For those who prefer established medications with extensive research, Wegovy remains excellent.

Feature-by-Feature Comparison

W

Wegovy

90
Z

Zepbound

92
Average Weight Loss~15%~22%
Retail Price$1,349/mo$1,059/mo
FDA Approval20212023
MechanismGLP-1GLP-1 + GIP
Long-term DataExtensiveGrowing
DosingWeeklyWeekly
Insurance CoverageVariableVariable
AvailabilityLimitedLimited
Visit Wegovy
Visit Zepbound
W

Choose Wegovy If...

  • You prefer a medication with more long-term data
  • Your insurance covers Wegovy but not Zepbound
  • You've tried tirzepatide and prefer semaglutide
  • Wegovy is more available in your area
Visit Wegovy
Z

Choose Zepbound If...

  • You want maximum weight loss potential
  • You prefer the dual-action mechanism
  • Your insurance covers Zepbound
  • You want the lower list price option
Visit Zepbound

Frequently Asked Questions

Affiliate Disclosure: We earn commissions from some provider links at no extra cost to you. This doesn't influence our rankings or reviews. Full disclosure

Get GLP-1 Updates

Weekly pricing updates, FDA news, and new provider reviews delivered to your inbox.

We may earn commissions from provider links. This doesn't affect our rankings. Disclosure